Healthcare

  • Another call for action on the fight against AMR

    Last week, the Review on Antimicrobial Resistance, published its final report on Tackling Drug-Resistant Infections Globally. The document represents an important call for action in the global fight against AMR and is expected to have a huge impact on the current debate. Setting the scene, the report states that 700,000 people die of drug-resistant infections…

  • First steps taken but still a long way to go to tackle antimicrobial resistance

    Last week, the European Parliament adopted its report on veterinary medicinal products advocating for the banning of collective and preventive antibiotic treatment of animals. The vote represents an important step in the fight against antimicrobial resistance (AMR) in Europe and Commissioner Andriukaitis strongly welcomed the EP report and the good work of Rapporteur, Mrs Grossetête.…

  • Meeting the challenges of patents, innovation and access to global health

    Over the past years, and as a response to the financial crisis in Europe, the pharmaceutical sector has felt the squeeze of cuts in healthcare spending. Not only have pharmaceutical companies had to re-adjust to the new market conditions, they have also been under the close scrutiny of the European Commission amidst claims of excessive…

  • German e-health law – a breakthrough for the digital health sector?

    Digitisation has become a political buzzword in Germany, raising particular concerns with regard to the German healthcare system. German politics has long been lagging behind in creating an appropriate framework that balances health benefits versus data protection issues. Now a new e-health law about to be passed, triggering a dynamic debate on digitisation, data and health.…

  • Medical Device Directive: state of play and future challenges

    The European Institutions have been working on the Directive on Medical Devices and In-Vitro Diagnostics since 2012. With the adoption of the European Parliament’s position in 2013 and the Council agreeing their approach in October 2015, the process has undoubtedly been slow. It was originally hoped that a conclusion would be finally reached by Christmas…

  • mHealth: Harnessing Growth and Innovation

    mHealth is changing the face of healthcare. While its potential is vast, the test for healthcare systems is to capture this value and translate it into concrete results. In our latest snapshot Kyra Obolensky and Lavinia Trehane from FTI Consulting’s healthcare team identify the challenges of building a robust and secure mHealth ecosystem and explore…

  • How to avoid slipping back to the ‘pre-penicillin era’

     This week the European Parliament adopted its own-initiative Report on Safer Healthcare in Europe: Improving Patient Safety and Fighting Antimicrobial Resistance. With this report MEPs are pointing to a looming global health crisis which requires urgent action on many fronts. In our latest snapshot Kyra Obolensky and Darren Kinsella from FTI Consulting’s healthcare team say…

  • What price medicine? A non-Brussels perspective on the EU’s role in shaping medicine prices.

    As part of our Healthy Thinking Series, on Tuesday 05 May FTI Consulting organised a debate on the role of the EU in the pricing and procurement of medicines. In order to broaden our perspective and move away from what can often be a technical debate we invited two speakers from outside the Brussels bubble,…

  • Our office is growing!

    It’s been an exciting start to the year here in Brussels with the addition of seven new team members to strengthen our Competition, Trade and Financial Services practices. The additions include senior professionals from within the European Commission including Massimo Baldinato, John Clancy, Kyra Obolensky and Roeland Van der Stappen as Senior Directors, Robrecht Vandormael…

  • The comeback of forgotten diseases

                      There are many diseases which Europe had presumed to be cured and therefore forgotten. For decades, diseases like polio and tuberculosis (TB) have been associated with developing countries and not those in the EU however recently, we are starting to see a worrying increase in incidents…

Back to top